Cigna Group (NYSE: CI) has outperformed the market over the past 20 years by 2.04% on an annualized basis producing an average annual return of 10.98%. Currently, Cigna Group has a market ...
Buying $1000 In LRCX: If an investor had bought $1000 of LRCX stock 20 years ago, it would be worth $39,760.90 today based on a price of $129.00 for LRCX at the time of writing.
Ratings for Stoke Therapeutics (NASDAQ: STOK) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ...
In the assessment of 12-month price targets, analysts unveil insights for NAPCO Security Techs, presenting an average target of $43.33, a high estimate of $50.00, and a low estimate of $36.00. This ...
Analysts have set 12-month price targets for Associated Banc, revealing an average target of $28.38, a high estimate of $32.00, and a low estimate of $27.00. This upward trend is evident, with the ...
TJX Companies has a better P/E ratio of 31.56 than the aggregate P/E ratio of 25.47 of the Specialty Retail industry. Ideally ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $17.58, a high estimate of $20.00, and a low estimate of $15.00. Surpassing the previous average price target ...
CommVault Systems (NASDAQ: CVLT) has outperformed the market over the past 5 years by 17.95% on an annualized basis producing an average annual return of 31.23%. Currently, CommVault Systems has a ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $207.64, a high estimate of $221.00, and a low estimate of $192.00. Highlighting a 1.39% decrease, the ...
PPG Indus (NYSE: PPG) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings, showcasing the ...
Buying $1000 In ALL: If an investor had bought $1000 of ALL stock 5 years ago, it would be worth $2,181.94 today based on a price of $205.67 for ALL at the time of writing.
Edwards Lifesciences (NYSE: EW) has outperformed the market over the past 15 years by 1.34% on an annualized basis producing an average annual return of 13.44%. Currently, Edwards Lifesciences has a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results